Edwards Lifesciences to acquire Innovalve Bio Medical for $300M

Edwards Lifesciences exercised an option to buy Innovalve Bio Medical, an Israel-based startup developing transcatheter mitral valve replacement technologies, for about $300 million in cash. The deal is expected to close by end of 2024.

“Edwards expects to pay about $300 million in cash at the closing of the acquisition, which is forecasted for the end of 2024.”medtechdive.com

• 1 source
• medtechdive.comEdwards to acquire Innovalve, stake in Affluent Medical | MedTech DiveSusan KellyJul 15, 2024

Summarized from public sources; check the original articles before acting on it.